Skip to main content
logo
Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
52.63
+0.12 (0.23%)
At close: Apr 10, 2026, 4:00 PM EDT
52.45
-0.18 (-0.34%)
Pre-market: Apr 13, 2026, 7:28 AM EDT

Soleno Therapeutics Revenue

In the year 2025, Soleno Therapeutics had annual revenue of $190.41M. Soleno Therapeutics had revenue of $91.73M in the quarter ending December 31, 2025.

Revenue (ttm)
$190.41M
Revenue Growth
n/a
P/S Ratio
14.30
Revenue / Employee
$1,046,181
Employees
182
Market Cap
2.72B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025190.41M--
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Travere Therapeutics490.73M
Arcus Biosciences247.00M
IDEAYA Biosciences218.71M
Beam Therapeutics139.74M
Tango Therapeutics62.38M
Relay Therapeutics15.36M
Celldex Therapeutics1.55M
Revenue Rankings

SLNO News

More News